Keith T. Demarest

Canagliflozin, a novel inhibitor of sodium glucose co‐transporter 2, dose dependently reduces calculated renal threshold for glucose excretion and increases urinary glucose excretion in healthy subjects

Sue Sha, Damayanthi Devineni, A. Ghosh et al. · Diabetes Obesity and Metabolism · 2011 · 292 citations

A Role for β-Cell-Expressed G Protein-Coupled Receptor 119 in Glycemic Control by Enhancing Glucose-Dependent Insulin Release

Zhi‐Liang Chu, Robert M. Jones, Hongmei He et al. · Endocrinology · 2007 · 292 citations

Effect of Canagliflozin on Renal Threshold for Glucose, Glycemia, and Body Weight in Normal and Diabetic Animal Models

Yin Liang, Kenji Arakawa, Kiichiro Ueta et al. · PLoS ONE · 2012 · 242 citations · Full text

Human cardiomyocytes express high level of Na⁺/glucose cotransporter 1 (SGLT1)

Lubing Zhou, Ellen V. Cryan, Michael R. D’Andrea et al. · Journal of Cellular Biochemistry · 2003 · 205 citations

Cardiac Muscle, Transcriptomics Technology, Cardiovascular Function +21

Reduction in Glucagon Receptor Expression by an Antisense Oligonucleotide Ameliorates Diabetic Syndrome in<i>db/db</i>Mice

Yin Liang, Melville C. Osborne, Brett P. Monia et al. · Diabetes · 2004 · 197 citations